{"id":242,"date":"2024-10-06T23:12:05","date_gmt":"2024-10-06T23:12:05","guid":{"rendered":"https:\/\/dev.therapeuticsolutionsint.com\/?page_id=242"},"modified":"2024-10-25T11:16:44","modified_gmt":"2024-10-25T11:16:44","slug":"sarcoma-stemvacs-h","status":"publish","type":"page","link":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/sarcoma-stemvacs-h\/","title":{"rendered":"Sarcoma &#8211; StemVacs-H"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311&#8243; custom_padding=&#8221;61px|||||&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-3cfc8c0c-5557-4a5d-9dab-24e78d615311%22:%91%22background_color%22%93}&#8221;][et_pb_row _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-47px|||||&#8221; custom_padding=&#8221;2px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>The following list of <strong>cancer immunotherapies<\/strong> are available for licensing under <a href=\"https:\/\/patents.justia.com\/patent\/20220235325\" target=\"_blank\" rel=\"noopener\">U.S. Patent Publication No.: <\/a><span><a href=\"https:\/\/patents.justia.com\/patent\/20220235325\" target=\"_blank\" rel=\"noopener\">20220235325<\/a>.<\/span><\/p>\n<p><strong>Stimulation of Dendritic Cell Activity by Homotaurine and Analogues Thereof<\/strong><\/p>\n<div class=\"horizontal layout style-scope patent-result\">\n<div class=\"flex-3 style-scope patent-result\" marginright=\"\">\n<section id=\"abstract\" class=\"style-scope patent-result\">\n<div class=\"flex style-scope patent-result\">Abstract<\/div>\n<div class=\"layout horizontal style-scope patent-text\">\n<section id=\"text\" class=\"flex style-scope patent-text\"><span>Disclosed are means, methods, and compositions of matter useful for enhancement of dendritic cell activity. In one embodiment the invention provides the use of GABA agonists such as homotaurine for stimulation of dendritic cell activity. In one embodiment said dendritic cell activity is enhancement of natural killer cell activity and\/or of T cell activity. In one embodiment NK cell activity is ability to induce cytotoxicity in neoplastically transformed cells, whereas T cell activity is either cytokine production for CD4 cells or cytotoxicity for CD8 cells.<\/span><\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-99px|auto||auto||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;-149px|||||&#8221; custom_padding=&#8221;51px|||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<html><br \/>\n<head><br \/>\n    <script src=\"https:\/\/ajax.googleapis.com\/ajax\/libs\/jquery\/1.12.4\/jquery.min.js\"><\/script><br \/>\n    <script>\n        $(function() {\n            $('.info').hide();\n            $('#countryList').on('change', function() {\n                $('.info').hide();\n                var countryCode = $('#countryList').val();\n                $('.info.' + countryCode).show();\n            });\n        });\n    <\/script><br \/>\n<\/head><br \/>\n<body><br \/>\n<select id=\"countryList\"><option value=\"\">[Select Disease]<\/option><option value=\"2\">Chondrosarcoma<\/option><option value=\"3\">Fibrosarcoma<\/option><option value=\"4\">Lymphosarcoma<\/option><option value=\"5\">Melano sarcoma<\/option><option value=\"6\">Myxosarcoma<\/option><option value=\"7\">Osteosarcoma<\/option><option value=\"8\">Endometrial sarcoma<\/option><option value=\"9\">Stromal sarcoma<\/option><option value=\"10\">Ewing&#8217;s sarcoma<\/option><option value=\"11\">Fascial sarcoma <\/option><option value=\"12\">Fibroblastic sarcoma<\/option><option value=\"13\">Giant cell sarcoma<\/option><option value=\"14\">Abemethy&#8217;s sarcoma<\/option><option value=\"15\">Adipose sarcoma<\/option><option value=\"16\">Liposarcoma<\/option><option value=\"17\">Alveolar soft part sarcoma<\/option><option value=\"18\">Ameloblastic sarcoma<\/option><option value=\"19\">Botryoid sarcoma<\/option><option value=\"20\">Chloroma sarcoma<\/option><option value=\"21\">Chorio carcinoma<\/option><option value=\"22\">Embryonal sarcoma<\/option><option value=\"23\">Wilns&#8217; tumor sarcoma<\/option><option value=\"24\">Granulocytic sarcoma<\/option><option value=\"25\">Hodgkin&#8217;s sarcoma<\/option><option value=\"26\">Idiopathic multiple pigmented hemorrhagic sarcoma<\/option><option value=\"27\">Immunoblastic sarcoma of b cells<\/option><option value=\"28\">Lymphoma<\/option><option value=\"29\">Immunoblastic sarcoma of t-cells<\/option><option value=\"30\">Kaposi&#8217;s sarcoma<\/option><option value=\"31\">Kupffer cell sarcoma<\/option><option value=\"32\">Angiosarcoma<\/option><option value=\"33\">Leukosarcoma<\/option><option value=\"34\">Malignant mesenchymoma sarcoma<\/option><option value=\"35\">Parosteal sarcoma<\/option><option value=\"36\">Reticulocytic sarcoma<\/option><option value=\"37\">Serocystic sarcoma<\/option><option value=\"38\">Synovial sarcoma<\/option><option value=\"39\">Telangiectaltic sarcoma<\/option><\/select><\/p>\n<div class=\"info 2\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Chondrosarcoma is a rare, malignant (cancerous) bone tumor made up of cartilage cells, the firm tissue that protects the ends of bones. These bone sarcomas usually start in the pelvis, chest, arms, or legs. They can grow fairly large\u2014often bigger than 4 centimeters across.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 3\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Fibrosarcomas are defined as malignant neoplasms composed of fibroblasts that may have varying amounts of collagen production and a &#8220;herringbone&#8221; architecture. Depending upon the origin, there are 2 main categories of fibrosarcomas: bone and soft tissue tumors.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 4\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Lymphosarcoma is highly malignant and, while the individual tumor may be affected by radiation, the course of the disease is usually progressive. Lymphosarcoma may arise in any organ which has a basic reticulum structure, i.e. lymphoid tissue, spleen, liver, or bone marrow.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 5\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Melano sarcoma  is a type of cancer that can occur in various locations in your body. Sarcoma is the general term for a broad group of cancers that begin in the bones.<br \/>\n<\/table>\n<\/div>\n<\/table>\n<\/div>\n<div class=\"info 6\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Myxosarcomas are neoplasms of fibroblast origin with abundant myxoid matrix of mucopolysaccharides.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 7\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Osteosarcoma (osteogenic sarcoma) is a type of cancer that starts in your bones. In the beginning, the cancer cells appear to be regular bone cells. Then, they create tumors, and those tumors create immature, irregular, diseased bone.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 8\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Endometrial sarcoma is a very rare type of uterine cancer, with characteristics of both endometrial cancer and uterine sarcoma.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 9\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Stromal sarcoma (ESS) is a rare malignant tumor of the endometrium, occurring in the age group of 40\u201350 years.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 10\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Ewing&#8217;S sarcoma is a type of tumor that forms from a certain kind of cell in bone or soft tissue. Undifferentiated small round cell sarcoma may also form in the bone or soft tissue.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 11\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Fascial sarcoma may develop in the muscles, fascia (the tough membrane surrounding muscles), tendons, fat, blood vessels, nerves, etc.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 12\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Fibroblastic sarcoma is a type of soft tissue sarcoma that begins due to the formation of abnormal mass in fibrous tissue.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 13\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Giant cell sarcoma  is one of the most common benign bone tumors, predominantly occurring in young adults aged 20 to 40 with a high recurrence rate and the potential for aggressive behavior. Typically found at the metaphyseal or epiphyseal regions of the tibia or femur, GCT, despite its predominantly benign nature, exhibits a highly unpredictable spectrum of disease behavior.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 14\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Abemethy&#8217;s sarcoma carries a high risk of hepatocellular carcinoma.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 15\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Adipose sarcoma is a cancer made up of fat cells, usually as a soft tissue sarcoma deep in the abdomen (belly), buttocks, arms, or legs. Liposarcomas may also occur as a rare esophageal cancer. Liposarcomas mostly affect middle-aged adults, from 50 to 65.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 16\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Liposarcoma is a rare type of cancer that develops in your fatty tissue. This type of tumor can grow anywhere in your body. Common places include your abdomen, thigh, and behind your knee. A liposarcoma is a malignant tumor. This means your cancer can spread to other areas, including vital organs.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 17\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Alveolar soft part sarcoma or ASPS, is a cancer that can come from different types of soft tissue, such as muscle, fat, or nerves.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 18\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Ameloblastic sarcoma is a rare malignant (cancerous) tumor that normally begins in the bones of the jaw.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 19\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Botryoid sarcoma is a variant of embryonal rhabdomyosarcoma that is characterized by the presence of a round, grape-like mass in the affected organ.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 20\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Chloroma sarcoma is a rare solid tumor composed of primitive precursors of the granulocytic series of WBC that include myeloblasts, promyelocytes, and myelocytes. This tumor was first described by Burns in 1811.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 21\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Chorio carcinoma is a malignant, fast-growing tumor that develops from trophoblastic cells (cells that help an embryo attach to the uterus and help form the placenta). Almost all choriocarcinomas form in the uterus after fertilization of an egg by a sperm, but a small number form in a testis or an ovary.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 22\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Embryonal sarcoma  of the liver (UESL) is an aggressive malignancy that most commonly affects the pediatric age group.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 23\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Wilns&#8217; tumor sarcoma is a type of childhood cancer that starts in the kidneys. It is the most common type of kidney cancer in children. About 9 of 10 kidney cancers in children are Wilms tumors. Cancer starts when cells in the body begin to grow out of control.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 24\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Granulocytic sarcoma is a rare type of cancer that is made up of myeloblasts (a type of immature white blood cell) and forms outside the bone marrow and blood.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 25\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Hodgkin&#8217;s sarcoma begins when healthy cells in the lymphatic system change and grow out of control. The lymphatic system includes lymph nodes.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 26\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Idiopathic multiple pigmented hemorrhagic sarcoma is characterized by red-purple or blue-brown lesions of the skin, mucous membranes, and other organs.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 27\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Immunoblastic sarcoma of b cells is a large cell lymphoma conceptually related to transformed T and B lymphocytes of the extrafollicular compartment of the immune system (immunoblasts).<br \/>\n<\/table>\n<\/div>\n<div class=\"info 28\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Lymphoma is a broad term for cancer that begins in cells of the lymph system. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Hodgkin lymphoma can often be cured. The prognosis of NHL depends on the specific type.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 29\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Immunoblastic sarcoma of t-cells is a large cell lymphoma conceptually related to transformed T and B lymphocytes of the extrafollicular compartment of the immune system (immunoblasts).<br \/>\n<\/table>\n<\/div>\n<div class=\"info 30\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Kaposi&#8217;s sarcoma is a type of cancer that forms in the lining of blood vessels and lymph vessels. The cancer forms growths of cells, called lesions, on the skin. The lesions often form on the face, arms and legs. The lesions may look pink, red, purple or brown.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 31\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Kupffer cell sarcomas form multiple gray macroscopic nodules that occur randomly through the liver. Histologically, they are composed of macrophage-like cells characterized by a pale, oval, indented nucleus surrounded by an abundant vacuolated cytoplasm.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 32\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Angiosarcoma is cancer that forms in the lining of blood vessels and lymph vessels. It often affects the skin and may appear as a bruise-like lesion that grows over time. Treatment depends on where the cancer is located.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 33\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Leukosarcoma is a type of rare cancer that grows in the smooth muscles. The smooth muscles are in the hollow organs of the body.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 34\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Malignant mesenchymoma sarcoma is a very rare type of cancer called a sarcoma. It: often grows in soft tissues, blood vessels, or organs like the intestines. mostly affects middle-aged adults.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 35\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Parosteal sarcoma s a subtype of osteosarcoma and arises from the outer layer of the periosteum.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 36\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Reticulocytic sarcoma, Like other dendritic cell sarcomas, fibroblastic reticular cell sarcomas affect adults and have been described in lymph nodes, spleen, and soft tissues.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 37\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Serocystic sarcoma are mostly benign lesions. Their incidence has increased recently due to the improvements in imaging techniques.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 38\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Synovial sarcoma is a cancer that can come from different types of soft tissue, such as muscle or ligaments. It is often found in the arm, leg, or foot, and near joints such as the wrist or ankle. It can also form in soft tissues in the lung or abdomen. Synovial sarcoma may also be called malignant synovioma.<br \/>\n<\/table>\n<\/div>\n<div class=\"info 39\">\n<table style=\"width:100%\">\n<table style=\"width:100%\">\n<tr>\n<th>Upfront Fee<\/th>\n<th>Annual Minimum Royalty<\/th>\n<th>Phase 1 IND<\/th>\n<th>Phase 2 IND<\/th>\n<th>Phase 3 IND<\/th>\n<th>BLA<\/th>\n<th>Royalty<\/th>\n<\/tr>\n<tr>\n<td>$50,000<\/td>\n<td>$10,000<\/td>\n<td>$100,000<\/td>\n<td>$250,000<\/td>\n<td>$500,000<\/td>\n<td>$1,000,000<\/td>\n<td>6%<\/td>\n<\/tr>\n<p>Telangiectaltic sarcoma is a rare high-grade malignant neoplasm, accounting for less than 10 percent of all cases of osteosarcoma.<br \/>\n<\/table>\n<\/div>\n<p><\/body><br \/>\n<\/html>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The following list of cancer immunotherapies are available for licensing under U.S. Patent Publication No.: 20220235325. Stimulation of Dendritic Cell Activity by Homotaurine and Analogues Thereof Abstract Disclosed are means, methods, and compositions of matter useful for enhancement of dendritic cell activity. In one embodiment the invention provides the use of GABA agonists such as [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-242","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/comments?post=242"}],"version-history":[{"count":4,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/242\/revisions"}],"predecessor-version":[{"id":372,"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/pages\/242\/revisions\/372"}],"wp:attachment":[{"href":"https:\/\/stemvacs.therapeuticsolutionsint.com\/index.php\/wp-json\/wp\/v2\/media?parent=242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}